GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Pre-Tax Income

Organon Pharma Indonesia PT (ISX:SCPI) Pre-Tax Income : Rp Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Organon Pharma Indonesia PT's pretax income for the three months ended in . 20 was Rp0.00 Mil. Organon Pharma Indonesia PT does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in . 20. Organon Pharma Indonesia PT's pretax margin was %.


Organon Pharma Indonesia PT Pre-Tax Income Historical Data

The historical data trend for Organon Pharma Indonesia PT's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Pre-Tax Income Chart

Organon Pharma Indonesia PT Annual Data
Trend
Pre-Tax Income

Organon Pharma Indonesia PT Quarterly Data
Pre-Tax Income

Competitive Comparison of Organon Pharma Indonesia PT's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organon Pharma Indonesia PT's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's Pre-Tax Income falls into.



Organon Pharma Indonesia PT Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Organon Pharma Indonesia PT's Pretax Income for the fiscal year that ended in . 20 is calculated as

Organon Pharma Indonesia PT's Pretax Income for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Pharma Indonesia PT  (ISX:SCPI) Pre-Tax Income Explanation

Organon Pharma Indonesia PT's Pretax Margin for the quarter that ended in . 20 is calculated as

Pretax Margin=Pretax Income/Revenue
=/
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Pharma Indonesia PT Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines